Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia
Authors:
- Tom TeerlinkTTTom Teerlink
- Coen van GuldenerCGCoen van Guldener
- Hubert A. PrinsHPHubert A. Prins
- Antonie A. van LambalgenALAntonie A. van Lambalgen
- Coen D. A. StehouwerCSCoen D. A. Stehouwer
- Jan A. RauwerdaJRJan A. Rauwerda
- Paul A. M. van LeeuwenPLPaul A. M. van Leeuwen
Open Access
- 6 November 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 18 (12) , 2542-2550
Abstract
Background. Asymmetrical dimethylarginine (ADMA) is capable of inhibiting nitric oxide synthase enzymes, whereas symmetrical dimethylarginine (SDMA) competes with arginine transport. The potential role of inflammation in the metabolism of ADMA has been elucidated in an in vitro model using tumour necrosis factor-α, resulting in a decreased activity of the ADMA-degrading enzyme dimethylarginine dimethylaminohydrolase (DDAH). The kidney probably plays a crucial role in the metabolism of ADMA by both urinary excretion and degradation by DDAH. We aimed to further elucidate the role of the kidney in a rat model under basal conditions and during endotoxaemia. Methods. Twenty-five male Wistar rats weighing 275–300 g were used for this study. The combination of arteriovenous concentration differences and kidney blood flow allowed calculation of net organ fluxes. Blood flow was measured using radiolabelled microspheres according to the reference sample method. Concentrations of ADMA, SDMA and arginine were measured by high-performance liquid chromatography. Results. The kidney showed net uptake of both ADMA and SDMA and fractional extraction rates were 35% and 31%, respectively. Endotoxaemia resulted in a lower systemic ADMA concentration (P = 0.01), which was not explained by an increased net renal uptake. Systemic SDMA concentrations increased during endotoxaemia (P = 0.007), which was accompanied by increased creatinine concentrations. Conclusions. The rat kidney plays a crucial role in the regulation of concentrations of dimethylarginines, as both ADMA and SDMA were eliminated from the systemic circulation in substantial amounts. Furthermore, evidence for the role of endotoxaemia in the metabolism of dimethylarginines was obtained as plasma levels of ADMA were significantly lower in endotoxaemic rats.Keywords
This publication has 24 references indexed in Scilit:
- Does ADMA Cause Endothelial Dysfunction?Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Endogenous Nitric Oxide Synthase InhibitorCirculation, 1999
- Hemodialysis Hypotension: Interaction of Inhibitors, iNOS, and the Interdialytic PeriodThe American Journal of the Medical Sciences, 1999
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998
- Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidneyKidney International, 1997
- Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive DiseaseCirculation, 1997
- Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2BNitric Oxide, 1997
- Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental HypertensionHypertension, 1997
- Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failureNephrology Dialysis Transplantation, 1996
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992